GUANGZHOU WONDFO BIOTECH CO.,LTD
万孚生物
GUANGZHOU WONDFO BIOTECH CO.,LTD
Biotech/Healthcare
Founded in 1992 with registered capital of RMB 88 million, Guangzhou Wondfo Biotech Co., Ltd. develops, manufactures, and sells point-of-care testing products, including reagents and instruments, for the in vitro diagnostics industry.
Latest round: Post-IPO (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.